Loading clinical trials...
Loading clinical trials...
Mesalazine (PENTASA®) in Ulcerative Colitis: Correlation of the Information Level With Patient's Compliance in Everyday Practice
Conditions
Interventions
Mesalazine
Locations
149
Germany
Investigational site, Wettinerstraße 22
Altenburg, Germany
Investigational site, Marienstraße 6
Amberg, Germany
Investigational site, Adam-Ries-Straße 57c
Annaberg-Buchholz, Germany
Investigational site, Goethestraße 5
Ansbach, Germany
Investigational site, Elisenstraße 32
Aschaffenburg, Germany
Investigational site, Prinzregentenstraße 8
Augsburg, Germany
Start Date
February 1, 2012
Primary Completion Date
December 1, 2013
Completion Date
December 1, 2013
Last Updated
October 1, 2015
NCT07271069
NCT06975722
NCT07185009
NCT07184996
NCT07245394
NCT07089420
Lead Sponsor
Ferring Pharmaceuticals
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions